NCT02028598 is a Phase 1 clinical trial of Treatment 1 in Healthy, sponsored by CTC Bio, Inc..

Who is sponsoring NCT02028598?

NCT02028598 is sponsored by CTC Bio, Inc..

What drugs are being tested in NCT02028598?

Interventions in NCT02028598: Treatment 1, Treatment 2, Treatment 3.

Is NCT02028598 still recruiting?

NCT02028598 is currently completed. Last updated 12 September 2014.

Last reviewed 2014-09-12 · How we verify

NCT02028598

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized, Open-labeled, 6-sequence, 3-period, 3-treatment Crossover Study to Evaluate the Effect of Co-administration of Clomipramine HCl (Condencia Tab.) 15mg and Sildenafil Citrate (Viagra Tab.) 100mg on the Safety and Pharmacokinetic/Pharmacodynamic Properties of Clomipramine and Sildenafil Compared to the Effects After Single Oral Administration in Healthy Male Volunteers

Completed Phase 1 Last updated 12 September 2014

What this trial tests

Phase 1 trial testing Treatment 1 in Healthy in 30 participants. Completed in 1 March 2014.

Timeline

1 January 2014

Primary endpoint
1 March 2014

1 March 2014

Quick facts

Lead sponsor	CTC Bio, Inc.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 January 2014
Primary completion	1 March 2014
Estimated completion	1 March 2014
Sites	1 location across South Korea

Drugs / interventions tested

Treatment 1 — full drug profile →
Treatment 2 — full drug profile →
Treatment 3 — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

CTC Bio, Inc. — full company profile →

Who can join

Adults 19 to 65, male only, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

The systemic exposure measured as area under the curve (AUC)
Time frame: From Day 1(dosing) to Day 4(72hrs)
The maximum concentration (Cmax)
Time frame: From Day 1(dosing) to Day 4(72hrs)

Sponsor's own description

The purpose of this study is to evaluate the safety and pharmacokinetics/pharmacodynamics of co-administration of Clomipramine HCl 15mg and Sildenafil citrate 100mg compared to the effects after single oral administration in Korean healthy male volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Treatment 1

Trials testing the same drug.

NCT06442293 — Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure. · NA · not yet recruiting
NCT02736331 — Different Types of Fruits on Metabolic Function and Cognitive Performance · NA · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other CTC Bio, Inc. trials

Trials by the same sponsor.

NCT04631874 — A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg" · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02028598 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CTC Bio, Inc.
Last refreshed: 12 September 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02028598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing